Tactile Systems Technology, Inc. (NASDAQ:TCMD) Expected to Announce Earnings of -$0.10 Per Share


Share on StockTwits

Equities analysts forecast that Tactile Systems Technology, Inc. (NASDAQ:TCMD) will report earnings per share (EPS) of ($0.10) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Tactile Systems Technology’s earnings. The highest EPS estimate is ($0.06) and the lowest is ($0.17). Tactile Systems Technology posted earnings of ($0.07) per share during the same quarter last year, which indicates a negative year-over-year growth rate of 42.9%. The firm is scheduled to announce its next earnings report on Monday, May 3rd.

According to Zacks, analysts expect that Tactile Systems Technology will report full-year earnings of $0.35 per share for the current fiscal year, with EPS estimates ranging from $0.18 to $0.47. For the next year, analysts anticipate that the firm will post earnings of $0.81 per share, with EPS estimates ranging from $0.74 to $0.87. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that that provide coverage for Tactile Systems Technology.

Tactile Systems Technology (NASDAQ:TCMD) last issued its earnings results on Tuesday, February 23rd. The company reported $0.61 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.39. Tactile Systems Technology had a negative net margin of 4.57% and a positive return on equity of 1.37%.

A number of analysts have recently issued reports on the stock. BTIG Research increased their price target on shares of Tactile Systems Technology from $51.00 to $60.00 and gave the stock an “in-line” rating in a research report on Monday, January 25th. TheStreet raised Tactile Systems Technology from a “d+” rating to a “c” rating in a report on Tuesday, February 23rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $59.00.

Several institutional investors and hedge funds have recently modified their holdings of TCMD. Everence Capital Management Inc. purchased a new position in shares of Tactile Systems Technology in the 1st quarter worth about $209,000. Dimensional Fund Advisors LP boosted its stake in shares of Tactile Systems Technology by 0.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 130,966 shares of the company’s stock worth $5,885,000 after buying an additional 774 shares during the last quarter. Hsbc Holdings PLC boosted its stake in shares of Tactile Systems Technology by 3.2% in the 4th quarter. Hsbc Holdings PLC now owns 12,072 shares of the company’s stock worth $543,000 after buying an additional 369 shares during the last quarter. Principal Financial Group Inc. raised its holdings in Tactile Systems Technology by 2.5% in the 4th quarter. Principal Financial Group Inc. now owns 142,288 shares of the company’s stock worth $6,394,000 after purchasing an additional 3,426 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in Tactile Systems Technology by 567.3% during the fourth quarter. JPMorgan Chase & Co. now owns 47,751 shares of the company’s stock valued at $2,146,000 after acquiring an additional 40,595 shares during the period.

Shares of TCMD stock traded up $0.79 during trading hours on Friday, reaching $53.34. The stock had a trading volume of 107 shares, compared to its average volume of 173,167. The firm has a 50-day simple moving average of $52.81 and a 200-day simple moving average of $45.94. The firm has a market capitalization of $1.04 billion, a PE ratio of -116.78, a price-to-earnings-growth ratio of 10.36 and a beta of 1.69. Tactile Systems Technology has a twelve month low of $30.31 and a twelve month high of $64.53.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.

Further Reading: How can you know how many shares are floating?

Get a free copy of the Zacks research report on Tactile Systems Technology (TCMD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tactile Systems Technology (NASDAQ:TCMD)

Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.